SAS Output

18-JUN-2019 6:10

LUNG ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1400-SCCA,Adv, Biomarker Master 1 N 1 Specimen Submission   1864 182 12 0 0 0 07/08/2014 455 223
            1864 182 12 0 0 0      
 
    2 Y 17 S1400G   61 0 0 0 0 0      
        2 S1400A   160 0 0 0 0 0 07/08/2014    
        21 S1400F   152 92 28 11 0 0      
        25 S1400K   50 20 0 0 0 0      
        29 S1800A   5 5 5 5 2 0      
        3 S1400B   53 0 0 0 0 0      
        30 S1900A   11 11 11 7 2 1      
        4 S1400C   88 0 0 0 0 0      
        5 S1400D   92 0 0 0 0 0      
        6 S1400E   16 0 0 0 0 0      
        7 S1400I   699 0 0 0 0 0      
            1387 128 44 23 4 1      
 
    3 P 10 S1400I   13 0 0 0 0 0      
        18 S1400G   10 0 0 0 0 0      
        22 S1400F   25 10 1 1 0 0      
        31 S1800A   2 2 2 2 0 0      
        32 S1900A   4 4 4 1 1 0      
        8 S1400B   1 0 0 0 0 0 07/08/2014    
            55 16 7 4 1 0      
 
    4 P 23 S1400F   3 0 0 0 0 0 07/08/2014    
            3 0 0 0 0 0      
 
  S1400F-Non-Match: MEDI4736 + Tremelimumab 1 T 1 MEDI4736 + Tremelimumab 132 64 43 16 6 0 0 11/30/2017 455 223
            64 43 16 6 0 0      
 
  S1619-Meso,Stg I-III, Nadj chemo/Atezmb->Atezmb+SOC 1 Y 1 Chemotherapy + Atezolizumab 28 17 17 10 7 1 0 07/16/2018 92 31
            17 17 10 7 1 0      
 
    2 Y 2 Surgery 28 6 6 5 3 0 0 07/16/2018    
            6 6 5 3 0 0      
 
    3 Y 3 Maintenance 28 6 6 5 4 0 0 07/16/2018    
            6 6 5 4 0 0      
 
  S1701-Thymic Adv, Carbo/Pac/Ram vs. Carbo/Pac 1 Y 1 Ramucirumab + Carbo/Paclitaxel 66 1 1 1 1 0 0 03/20/2019 94 31
            1 1 1 1 0 0      
 
  S1800A-Non-Match: Ramu + Pembro vs SoC 1 Y 1 Standard of Care (Inv. Choice) 144 1 1 1 1 1 0 05/28/2019 134 52
        2 Ramucirumab + Pembrolizumab   1 1 1 1 1 0      
            2 2 2 2 2 0      
 
  S1900A-LOH and/or BRCA: Rucaparib 1 Y 1 Rucaparib 88 6 6 6 6 4 1 04/16/2019 200 93
            6 6 6 6 4 1      
 
  LUNGMAP-NSCLC, Adv, Master 0 Y 0 ctDNA Specimen Submission   46 46 46 35 9 1 02/06/2019 314 154
            46 46 46 35 9 1      
 
    1 Y 1 Tissue Submission   274 274 274 213 83 15 02/06/2019    
            274 274 274 213 83 15      
 
    2 Y 2 S1400F   10 10 10 7 1 0 02/06/2019    
        4 S1800A   51 51 51 51 25 7      
        5 S1900A   11 11 11 10 5 2      
            72 72 72 68 31 9      
 
Yes A081105-ALCHEMIST1, EGFR mut, Erlotinib 1 E Total Registrations   55 16 10 4 0 0 04/01/2015 501 278
            55 16 10 4 0 0      
 
  A151216-ALCHEMIST0 - screening 1 E Total Registrations   720 195 81 48 11 3 12/16/2014 499 280
            720 195 81 48 11 3      
 
  C30610-SCLC, Thoracic RT 1 E Total Registrations   57 1 1 0 0 0 05/14/2008 157 85
            57 1 1 0 0 0      
 
  E4512-ALCHEMIST2, ALK mut, Crizotinib 1 E Total Registrations   12 4 1 0 0 0 02/29/2016 383 219
            12 4 1 0 0 0      
 
  NRGCC003-SCLC, PCI or HA-PCI 1 E Total Registrations   4 0 0 0 0 0 10/20/2016 241 123
            4 0 0 0 0 0      
 
    2 E Total Registrations   4 0 0 0 0 0 10/20/2016    
            4 0 0 0 0 0      
 
No A151216-ALCHEMIST0 - screening 0 E Total Registrations   738 207 91 55 16 6 12/16/2014 499 280
            738 207 91 55 16 6      
 
  EA5142-ALCHEMIST3, Non-match, Nivolumab 1 E Total Registrations   110 61 31 15 2 1 08/03/2016 468 270
            110 61 31 15 2 1      
 
  EA5163-NSCLC, Immunotherapy +/- 2nd line therapy 1 E Total Registrations   2 2 2 2 2 0 05/30/2019 30 11
            2 2 2 2 2 0      
 

18-JUN-2019 6:10

LUNG Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
LUNGMAP NSCLC, Adv, Master 3 Sub-study Assignment II 28-Jan-19
  4 Sub-study Assignment III 28-Jan-19
  5 Sub-study Assignment IV 28-Jan-19